Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.
Associated Press - December 21, 2005
The FDA said it was giving tentative approval for Stavudine, an antiretroviral drug considered child-friendly that is manufactured by Aurobindo Pharma Ltd. of Hyderabad, India.
Stavudine for oral solution is the first generic version of the previously approved Zerit for oral solution manufactured by Bristol-Myers Squibb.
The generic version meets FDA manufacturing, safety and efficacy standards but will not be marketed in the United States for patent exclusivity reasons, the agency said.
The approval does mean, however, that the generic version can be used by relief organizations outside the United States funded by President Bush's $15 billion AIDS relief plan.
___
On the Net:
FDA information on HIV/AIDS: www.fda.gov/oashi/aids/hiv.html
051221
AP051230
Copyright © 2005 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .